Biomarker and Assay Development

Dr. Nicole Schneiderhan-Marra
Head of Pharma & Biotech
Dr. Markus Templin
Group Leader Assay Development
Dr. Jens Göpfert
Group Leader Applied Biomarkers and Immunoassays

Unlock the secrets of biological changes with our accurate and reliable antibody-based detection systems

Biological or pathological processes lead to changes in the composition of the proteome. Accurate analysis of such changes is performed by biomarker analysis using antibody-based detection systems. We offer high-quality customized analytical solutions ranging from conventional ELISAs to highly sensitive immunoassays for exactly this purpose.

 

Our services
Development of sandwich immunoassays on multiple platforms:

  • Preparation of reagents for immunoassays

  • Optimization of assay reagents

  • Fine-tuning of assay conditions

  • Development of prototype assays or fully optimized assays

  • From conventional to ultrasensitive immunoassays

  • Increase efficiency and throughput rates through automation

  • Reliable and consistent results through standardized reagent preparation

 

Available technologies

  • Singleplex and multiplex bead-based immunoassays (Luminex® platform).

  • Enzyme-linked immunosorbent assay (ELISA)

  • Ultrasensitive bead-based immunoassays (SIMOA® HD-X platform from QuanterixTM)

  • Ultrasensitive planar immunoassays (SIMOA® SP-X platform from QuanterixTM)

  • High- and ultrasensitive immunoassays on the SIMOA® platform under GCP regulations.

 

Services

  • GCP-compliant analysis of clinical trial samples with highly sensitive immunoassays (SIMOA HD-X, SIMOA SP-X platforms).
  • Analysis of exploratory, preclinical and clinical study samples with commercially available assay kits (e.g. Quanterix/SIMOA®, Luminex®, ELISA)
  • Biomarker identification
  • Evaluation of assay technologies
  • Consulting on immunoassay technologies and protein-protein interaction analysis
  • Automation of immunoassays and reagent preparation
  • Customized assay validations according to EMA/FDA/ICH or CLSI guidelines
  • Electrophoresis (SDS-PAGE, Western blot) for protein analysis

 

Methods

  • Multiplexe Immunoassays
  • Singleplexe Immunoassays
  • Hoch-/Ultrasensitive Immunoassays
  • ELISAs

 

Instruments

  • Multiple Luminex FLEXMAP 3D® and Luminex® xMAP® INTELLIFLEX instruments
  • Multiple Quanterix® HD-X instruments
  • Quanterix® SP-X Instrument
  • ELISA Reader
  • Kingfisher Flex (Thermo Scientific) automated bead-handling systems

Services

  • GCP-compliant analysis of clinical trial samples with highly sensitive immunoassays (SIMOA HD-X, SIMOA SP-X platforms)
  • Analysis of exploratory, preclinical and clinical study samples with commercially available assay kits (e.g. Quanterix/SIMOA®, Luminex®, ELISA)
  • Biomarker identification
  • Evaluation of assay technologies
  • Consulting on immunoassay technologies and protein-protein interaction analysis
  • Automation of immunoassays and reagent production
  • Customized assay validations according to EMA/FDA/ICH or CLSI guidelines
  • Electrophoresis (SDS-PAGE, Western blot) for protein analysis